open access

Vol 78, No 4 (2010)
ORIGINAL PAPERS
Published online: 2010-07-08
Submitted: 2013-02-22
Get Citation

Is prediction of the allergic march possible on the basis of nasal cytology?

Zygmunt Nowacki, Jolanta Neuberg, Krystyna Strzałka, Magdalena Szczepanik, Renata Szczepanik, Henryk Mazurek
Pneumonol Alergol Pol 2010;78(4):263-270.

open access

Vol 78, No 4 (2010)
ORIGINAL PAPERS
Published online: 2010-07-08
Submitted: 2013-02-22

Abstract


Introduction: The term allergic march has been used to describe natural evolution of the atopic disease in children, accompanied by the change in organ manifestation with time. The aim of the study was to analyze the role of the cellular components of the nasal cytology as a tool for prediction of atopic diseases and clinical symptoms preceding allergic march.
Material and methods: In a retrospective manner out of a group of 1620 children, 146 symptomatic children (60 girls and 86 boys) meeting inclusion criteria (age below 4 years at first visit, symptoms suggesting allergy, nasal cytology performed at the beginning of observation, observation of at least 4 years) were included in analysis.
Results: Mean age of children at time of enrollment was 27 months (SD 10 months). After 4 years allergic rhinitis (AR) was diagnosed in 85 children (58.2%), atopic eczema/dermatitis syndrome (AEDS) in 51 (34.9%) and asthma in 48 (32.9%). Nonallergic etiology was identified in 36 patients (22.5%). All patients with asthma suffered from AR. Significant differences between groups were found in number of eosinophils (p < 0.001), neutrophils (p < 0.001), and lymphocytes (p = 0.028) in cytological examination of nasal mucosa. In children with AR (alone or combined with other comorbidities) nasal eosinophilia was higher than in children with AEDS (18% v. 3%; p = 0.004) or non-allergic disease (18% v. 4%; p < 0.001). Nasal eosinophilia of at least 8% was predictive for development of AR (sensitivity 80%, specificity 95%).
Conclusions: In children below 4 years nasal eosinophilia ≥ 8% was predictive for AR development. Allergic march was observed in children with AEDS or/and gastrointestinal allergy symptoms present at the beginning of observation. Nasal eosinophilia in small children might be predictive for the risk of allergic march.
Pneumonol. Alergol. Pol. 2010; 78, 4: 263-270

Abstract


Introduction: The term allergic march has been used to describe natural evolution of the atopic disease in children, accompanied by the change in organ manifestation with time. The aim of the study was to analyze the role of the cellular components of the nasal cytology as a tool for prediction of atopic diseases and clinical symptoms preceding allergic march.
Material and methods: In a retrospective manner out of a group of 1620 children, 146 symptomatic children (60 girls and 86 boys) meeting inclusion criteria (age below 4 years at first visit, symptoms suggesting allergy, nasal cytology performed at the beginning of observation, observation of at least 4 years) were included in analysis.
Results: Mean age of children at time of enrollment was 27 months (SD 10 months). After 4 years allergic rhinitis (AR) was diagnosed in 85 children (58.2%), atopic eczema/dermatitis syndrome (AEDS) in 51 (34.9%) and asthma in 48 (32.9%). Nonallergic etiology was identified in 36 patients (22.5%). All patients with asthma suffered from AR. Significant differences between groups were found in number of eosinophils (p < 0.001), neutrophils (p < 0.001), and lymphocytes (p = 0.028) in cytological examination of nasal mucosa. In children with AR (alone or combined with other comorbidities) nasal eosinophilia was higher than in children with AEDS (18% v. 3%; p = 0.004) or non-allergic disease (18% v. 4%; p < 0.001). Nasal eosinophilia of at least 8% was predictive for development of AR (sensitivity 80%, specificity 95%).
Conclusions: In children below 4 years nasal eosinophilia ≥ 8% was predictive for AR development. Allergic march was observed in children with AEDS or/and gastrointestinal allergy symptoms present at the beginning of observation. Nasal eosinophilia in small children might be predictive for the risk of allergic march.
Pneumonol. Alergol. Pol. 2010; 78, 4: 263-270
Get Citation

Keywords

nasal cytology; allergic march; allergic rhinitis; asthma

About this article
Title

Is prediction of the allergic march possible on the basis of nasal cytology?

Journal

Advances in Respiratory Medicine

Issue

Vol 78, No 4 (2010)

Pages

263-270

Published online

2010-07-08

Bibliographic record

Pneumonol Alergol Pol 2010;78(4):263-270.

Keywords

nasal cytology
allergic march
allergic rhinitis
asthma

Authors

Zygmunt Nowacki
Jolanta Neuberg
Krystyna Strzałka
Magdalena Szczepanik
Renata Szczepanik
Henryk Mazurek

References (30)
  1. Borres MP, Einarsson R, Björkstén B. Serum levels of interleukin-4, soluble CD23 and IFN gamma in relation to the development of allergic disease during the first 18 months of life. Clin Exp Allergy. 1995; 25(6): 543–548.
  2. Kjellman NI. Predictive value of high IgE levels in children. Acta Paediatr Scand. 1976; 65(4): 465–471.
  3. Hansel F. Observations on the cytology of the secretions in allergy of the nose and paranasal sinuses. Journal of Allergy. 1934; 5(4): 357–366.
  4. MATHESON A, ROSENBLUM A, GLAZER R, et al. Local tissue and blood eosinophils in newborn infants. J Pediatr. 1957; 51(5): 502–509.
  5. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000; 55(2): 116–134.
  6. Bousquet J, Khaltaev N, Cruz AA, et al. World Health Organization, GA(2)LEN, AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63 Suppl 86: 8–160.
  7. Miszke A, Sanokowska E, Chomiak E. Cytologia zdrowej błony śluzowej nosa. Otolaryngol Pol. 1985; 39: 25–31.
  8. Miszke A, Sanokowska E. Nowe normy cytologiczne dla śluzówki nosa. Otolaryngol Pol. 1994; 47: 44–47.
  9. Miszke A, Sanokowska E. Wartość diagnostyczna cytologii błony śluzowej nosa. Otolaryngol Pol. 1999; 53: 253–256.
  10. Williams HC, Burney PG, Pembroke AC, et al. The U.K. Working Party’s diagnostic criteria for atopic dermatitis. III Independent hospital validation Br J Dermatol. 1994; 131: 406–416.
  11. The Global Strategy for Asthma Management and Prevention. http:www.ginasthma.org (2008).
  12. Gustafsson D, Sjöberg O, Foucard T. Sensitization to food and airborne allergens in children with atopic dermatitis followed up to 7 years of age. Pediatr Allergy Immunol. 2003; 14(6): 448–452.
  13. Eichenfield LF, Hanifin JM, Beck LA, et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics. 2003; 111(3): 608–616.
  14. Papadopoulos NG, Borres M, Gern J, et al. New visions in respiratory allergy (asthma and allergic rhinitis): an iPAC summary and future trends. Pediatr Allergy Immunol. 2008; 19 Suppl 19: 51–59.
  15. Ciprandi G, Milanese M, Tosca MA, et al. Nasal eosinophils correlate with FEV1 in patients with perennial allergic rhinitis associated to asthma. Eur Ann Allergy Clin Immunol. 2004; 36: 363–365.
  16. Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy. 2000; 30(5): 663–669.
  17. Illi S, von Mutius E, Lau S, et al. Multicenter Allergy Study Group. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004; 113(5): 925–931.
  18. Bergmann RL, Edenharter G, Bergmann KE, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy. 1998; 28(8): 965–970.
  19. Piippo-Savolainen E, Remes S, Kannisto S, et al. Asthma and lung function 20 years after wheezing in infancy: results from a prospective follow-up study. Arch Pediatr Adolesc Med. 2004; 158(11): 1070–1076.
  20. Marenholz I, Nickel R, Rüschendorf F, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006; 118(4): 866–871.
  21. von Berg A, Filipiak-Pittroff B, Krämer U, et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol. 2008; 121(6): 1442–1447.
  22. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy. 2004; 34(6): 891–896.
  23. Droszcz W. Badania dodatkowe i konsultacje w chorobach układu oddechowego — zarys postępowania w pracy lekarza. Alergia. 2004; 3: 16–17.
  24. Passalacqua G, Canonica GW. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther. 2005; 27(7): 979–992.
  25. Blomgren K, Simola M, Hytönen M, et al. Peak nasal inspiratory and expiratory flow measurements--practical tools in primary care? Rhinology. 2003; 41(4): 206–210.
  26. Tarchalska-Kryńska B, Modrzyński M. Ocena cytologiczna błony śluzowej nosa u dzieci z przerostem migdałka gardłowego. Cz II Pol Merk Lek. 2001; 60: 408.
  27. Gustafsson D, Sjöberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age. Allergy. 2000; 55(3): 240–245.
  28. Burke W, Fesinmeyer M, Reed K, et al. Family history as a predictor of asthma risk. Am J Prev Med. 2003; 24(2): 160–169.
  29. Sale R, Silvestri M, Battistini E, et al. Nasal inflammation and bronchial reactivity to methacholine in atopic children with respiratory symptoms. Allergy. 2003; 58(11): 1171–1175.
  30. Fokkens W, Lund V, Bachert C, et al. EAACI. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005; 60(5): 583–601.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl